File(s) under permanent embargo
Successful add-on viloxazine to clozapine-responsive schizophrenia mitigated cognitive, negative and metabolic domains
journal contribution
posted on 2023-05-22, 04:14 authored by Naguy, A, Rushdy, R, Saxby PridmoreSaxby Pridmore, Singe, A, Alamiri, BEarly-onset schizophrenia is notorious for poor prognostication and treatment-refractoriness. Clozapine remains a viable option, albeit off-label, but is clearly underutilized in this population. Use is typically fraught with panoply of drastic side effects. Here, authors report on an adolescent case with schizophrenia that responded ultimately to clozapine. Add-on viloxazine was advantageous spanning different symptom domains, mitigating metabolic parameters and addressing clozapine-sialorrhea. This might open new venues for such complicated, yet commonplace, clinical scenarios.
History
Publication title
Psychopharmacology BulletinVolume
52Pagination
57-60ISSN
2472-2448Department/School
Tasmanian School of MedicinePublisher
MedWorks Media LLCPlace of publication
United StatesRepository Status
- Restricted